January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
December 22, 2024 What About Federal Reserve Rates Cut?
December 20, 2024 Honda-Nissan Alliance: A Bold Move To Dominate Auto Industry
December 13, 2024 Trump’s Plan: Potential Shake-Up For Bank Regulators
Tesla: High Hopes, Low Deliveries
Nvidia: Don’t Expect Major Gains From Here (Technical Analysis)
3M Company: Laying The Groundwork For Margin Expansion
Pop Goes The Tesla (Our Top Short For 2025)
Apple: A Piece Of This Pie Is Too Expensive For Me
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
December 21, 2024 Best Economic Calendars For Traders
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
Nuvectis Pharma (NVCT) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: January 17, 2025 (01:28)
Sector: HealthcareThe share price of Nuvectis Pharma, Inc. (NVCT) now
Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2025, 2026, 2027. How much will one Nuvectis Pharma share be worth in 2025 - 2027?
When should I take profit in Nuvectis Pharma stock? When should I record a loss on Nuvectis Pharma stock? What are analysts' forecasts for Nuvectis Pharma stock? What is the future of Nuvectis Pharma stock? We forecast Nuvectis Pharma stock performance using neural networks based on historical data on Nuvectis Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Nuvectis Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Nuvectis Pharma shares. This happens once a day.
Historical and forecast chart of Nuvectis Pharma stock
The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Nuvectis Pharma stock price can be found in the table below.
Long-term forecasts by years.
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Nuvectis Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan 18 | 5.59 | 5.50 | 5.79 | 5.30 |
| Jan 19 | 5.54 | 5.46 | 5.78 | 5.84 |
| Jan 20 | 5.25 | 5.13 | 5.35 | 4.42 |
| Jan 21 | 5.12 | 5.04 | 5.36 | 6.40 |
| Jan 22 | 5.15 | 5.08 | 5.31 | 4.56 |
| Jan 23 | 5.29 | 5.17 | 5.41 | 4.67 |
| Jan 24 | 5.25 | 5.10 | 5.43 | 6.42 |
| Jan 25 | 5.19 | 4.99 | 5.33 | 6.87 |
| Jan 26 | 5.04 | 4.88 | 5.24 | 7.45 |
| Jan 27 | 4.87 | 4.73 | 4.99 | 5.57 |
| Jan 28 | 4.87 | 4.80 | 5.07 | 5.72 |
| Jan 29 | 4.94 | 4.72 | 5.13 | 8.47 |
| Jan 30 | 4.91 | 4.78 | 5.01 | 4.94 |
| Jan 31 | 5.07 | 4.85 | 5.26 | 8.47 |
| Feb 01 | 5.28 | 5.08 | 5.52 | 8.74 |
| Feb 02 | 5.13 | 4.99 | 5.33 | 6.78 |
| Feb 03 | 5.12 | 4.89 | 5.20 | 6.15 |
| Feb 04 | 5.21 | 5.09 | 5.28 | 3.88 |
| Feb 05 | 5.28 | 5.19 | 5.37 | 3.48 |
| Feb 06 | 5.00 | 4.86 | 5.14 | 5.67 |
| Feb 07 | 5.07 | 4.83 | 5.27 | 9.07 |
| Feb 08 | 4.81 | 4.72 | 4.99 | 5.74 |
| Feb 09 | 4.75 | 4.65 | 4.90 | 5.40 |
| Feb 10 | 5.02 | 4.87 | 5.24 | 7.61 |
| Feb 11 | 5.25 | 5.18 | 5.43 | 4.80 |
| Feb 12 | 5.55 | 5.33 | 5.76 | 7.99 |
| Feb 13 | 5.38 | 5.17 | 5.57 | 7.81 |
| Feb 14 | 5.16 | 4.93 | 5.40 | 9.61 |
| Feb 15 | 5.23 | 5.01 | 5.30 | 5.76 |
| Feb 16 | 5.36 | 5.11 | 5.50 | 7.54 |
Nuvectis Pharma Daily Price Targets
Nuvectis Pharma Stock Forecast 01-18-2025.
Forecast target price for 01-18-2025: $5.59.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.036%.
Pessimistic target level: 5.50
Optimistic target level: 5.79
Nuvectis Pharma Stock Forecast 01-19-2025.
Forecast target price for 01-19-2025: $5.54.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.521%.
Pessimistic target level: 5.46
Optimistic target level: 5.78
Nuvectis Pharma Stock Forecast 01-20-2025.
Forecast target price for 01-20-2025: $5.25.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 4.234%.
Pessimistic target level: 5.13
Optimistic target level: 5.35
Nuvectis Pharma Stock Forecast 01-21-2025.
Forecast target price for 01-21-2025: $5.12.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.018%.
Pessimistic target level: 5.04
Optimistic target level: 5.36
Nuvectis Pharma Stock Forecast 01-22-2025.
Forecast target price for 01-22-2025: $5.15.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 4.361%.
Pessimistic target level: 5.08
Optimistic target level: 5.31
Nuvectis Pharma Stock Forecast 01-23-2025.
Forecast target price for 01-23-2025: $5.29.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 4.458%.
Pessimistic target level: 5.17
Optimistic target level: 5.41
NVCT (NVCT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb. | 6.61 | 6.03 | 7.22 | 16.48 |
| Mar. | 7.50 | 6.94 | 7.83 | 11.30 |
| Apr. | 8.04 | 7.38 | 8.79 | 16.09 |
| May. | 8.65 | 7.63 | 9.96 | 23.44 |
| Jun. | 9.24 | 8.04 | 10.59 | 24.08 |
| Jul. | 8.83 | 8.09 | 9.55 | 15.34 |
| Aug. | 9.04 | 8.28 | 9.48 | 12.60 |
| Sep. | 8.32 | 7.75 | 9.52 | 18.53 |
| Oct. | 7.64 | 6.48 | 8.52 | 24.01 |
| Nov. | 8.90 | 8.01 | 9.51 | 15.73 |
| Dec. | 8.35 | 7.67 | 9.12 | 15.93 |
Nuvectis Pharma forecast for this year
Nuvectis Pharma Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $6.61178. Pessimistic: $6.03. Optimistic: $7.22
Nuvectis Pharma Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $7.49776. Pessimistic: $6.94. Optimistic: $7.83
Nuvectis Pharma Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $8.0376. Pessimistic: $7.38. Optimistic: $8.79
Nuvectis Pharma Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $8.64845. Pessimistic: $7.63. Optimistic: $9.96
Nuvectis Pharma Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $9.23655. Pessimistic: $8.04. Optimistic: $10.59
Nuvectis Pharma Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $8.83014. Pessimistic: $8.09. Optimistic: $9.55
Nuvectis Pharma Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $9.04206. Pessimistic: $8.28. Optimistic: $9.48
Nuvectis Pharma Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $8.3187. Pessimistic: $7.75. Optimistic: $9.52
Nuvectis Pharma Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $7.63657. Pessimistic: $6.48. Optimistic: $8.52
Nuvectis Pharma Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $8.90424. Pessimistic: $8.01. Optimistic: $9.51
Nuvectis Pharma Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $8.35217. Pessimistic: $7.67. Optimistic: $9.12
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.15 | 6.15 | 7.64 | 19.48 |
| Feb | 8.44 | 7.63 | 9.38 | 18.71 |
| Mar | 9.47 | 8.24 | 10.43 | 21.05 |
| Apr | 9.73 | 8.76 | 10.96 | 20.07 |
| May | 8.82 | 8.20 | 10.09 | 18.71 |
| Jun | 9.05 | 7.92 | 10.49 | 24.48 |
| Jul | 9.41 | 8.54 | 10.25 | 16.70 |
| Aug | 9.54 | 8.45 | 10.32 | 18.11 |
| Sep | 9.75 | 8.79 | 10.82 | 18.74 |
| Oct | 10.35 | 8.92 | 11.55 | 22.76 |
| Nov | 10.99 | 9.96 | 12.71 | 21.63 |
| Dec | 10.95 | 10.38 | 11.41 | 9.02 |
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 12.05 | 10.41 | 13.95 | 25.39 |
| Feb | 11.28 | 10.40 | 12.02 | 13.51 |
| Mar | 13.26 | 11.99 | 14.43 | 16.91 |
| Apr | 15.88 | 14.01 | 17.63 | 20.54 |
| May | 15.09 | 13.91 | 16.00 | 13.02 |
| Jun | 13.94 | 12.24 | 14.59 | 16.06 |
| Jul | 12.41 | 11.24 | 13.38 | 15.96 |
| Aug | 13.03 | 11.23 | 14.70 | 23.58 |
| Sep | 13.58 | 11.54 | 14.83 | 22.16 |
| Oct | 15.26 | 14.53 | 16.91 | 14.08 |
| Nov | 13.89 | 12.53 | 16.11 | 22.24 |
| Dec | 14.64 | 13.06 | 15.98 | 18.31 |
Nuvectis Pharma information and performance
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, US
Market capitalization of the Nuvectis Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVCT shares in the company outstanding by the market price of one share.
EBITDA of Nuvectis Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
